PharmaCielo Ltd. (PCLO.V) Stock Price & Growth Analysis

Quote Panel

Updated October 22, 2024

1W -13.64 % 1M -20.83 % 3M -34.48 % 1Y -60.42 %

Key Metrics

Market Cap
13.45M
Shares Outstanding
141.60M
Share in Float
131.59M
Dividende
0

Earning Date
26 Nov 2024
Price Target
0.095
Average Volume
120762
Beta
2.44

Range
0.085-0.29
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.pharmacielo.com
Sector
Healthcare

Fundamentals

N/A

P/E Ratio

8.31x

P/S Ratio

-2.97x

P/B Ratio

-3.7

Debt/Equity

-873.6%

Net Margin

$-0.1

EPS

How PCLO.V compares to sector?

P/E Ratio

Relative Strength

PCLO.V

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$49M

6121%

2024-Revenue

$49M

-3809%

2024-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.22

N/A

-0.02
vs -0.05

Q2.22

N/A

-0.02
vs -0.04

Q3.22

N/A

-0.04
vs -0.06

Q4.22

N/A

-0.03
vs -0.03

Q1.23

N/A

-0.02
vs -0.02

Q2.23

N/A

-0.02
vs -0.02

Q3.23

N/A

-0.02
vs -0.04

Q4.23

N/A

-0.04
vs -0.03

Q1.24

N/A

-0.01
vs -0.02

Q2.24

N/A

-0.02
vs -0.02

Sales Growth

YoY

Current

Estimates

Q1.22

+78%

1.2M vs 675.3K

Q2.22

+375%

2.1M vs 446K

Q3.22

-2%

475.3K vs 485.2K

Q4.22

+347%

1.5M vs 338.6K

Q1.23

-35%

786.5K vs 1.2M

Q2.23

-92%

159.5K vs 2.1M

Q3.23

-26%

351.7K vs 475.3K

Q4.23

-84%

244K vs 1.5M

Q1.24

-69%

240.3K vs 786.5K

Q2.24

+391%

783.7K vs 159.5K

Return on Equity

QoQ

Q3.22

-59%

-0.59
vs -0.26

Q4.22

-66%

-0.66
vs -0.59

Q1.23

-81%

-0.81
vs -0.66

Q2.23

-101%

-1.01
vs -0.81

Q3.23

-99%

-0.99
vs -1.01

Q4.23

+381%

3.81
vs -0.99

Q1.24

+72%

0.72
vs 3.81

Q2.24

+47%

0.47
vs 0.72

Institutionnal Ownership

Company Description

N/A

8.31x

-2.97x

-3.7

-873.6%

$-0.1

$49M

$49M

Earnings Growth

Latest News

New Feature Coming Soon, Stay Tuned!